HOOKIPA Pharma Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q1 2025.

Symbol
HOOK on OTC
Location
New York, NY
Fiscal year end
31 December
Latest financial report
15 May 2025

Quick Takeaways

  • HOOK - HOOKIPA Pharma Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q1 2025.
  • Headline metric: Return On Equity -106%.

What Changed

  • Return On Equity YoY change: <span class="text-green-600">+109%</span>.
  • Most recent SEC facts end date: 31 Mar 2025.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2025-03-31) highlights Return On Equity -105.8%, Return On Assets -70.8%, and Operating Margin -860.2%.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

25.0/100

Weak Confidence high

Return On Equity

-106%

Metric score 0.0/100

Return On Assets

-71%

Metric score 0.0/100

Financial Health

Current Ratio
3.61x
Quick Ratio
2.45x
Debt to Equity
0.56x

Strengths

Debt-to-equity

Watchpoints

Return On Equity, Return On Assets, and Operating Margin

Key metrics snapshot

Return On Equity

-106%

YoY: +109%

Industry median: -43% (n=675)

View history

Return On Assets

-71%

YoY: +130%

Industry median: -47% (n=673)

View history

Operating Margin

-860%

YoY: +621%

Industry median: -121% (n=298)

View history

Current Ratio

3.61x

YoY: -20%

Industry median: 3.39x (n=667)

View history

Quick Ratio

2.45x

YoY: -30%

Industry median: 1.51x (n=289)

View history

Debt-to-equity

0.56x

YoY: -14%

Industry median: 0.26x (n=530)

View history

Revenues YoY

-83%

YoY:

Industry median: 7.3% (n=302)

View history

NetIncomeLoss YoY

-54%

YoY:

Industry median: -0.93% (n=641)

View history

Profitability

Metric Latest value YoY change
Return On Equity -106% +109%
Return On Assets -71% +130%
Operating Margin -860% +621%

Financial Health

Metric Latest value YoY change
Current Ratio 3.61x -20%
Quick Ratio 2.45x -30%
Debt-to-equity 0.56x -14%

Growth

Metric Latest value YoY change
Revenues YoY -83%
NetIncomeLoss YoY -54%

Share Metrics

Metric Latest value YoY change
Weighted Average Number of Shares Outstanding, Basic 12,544,777 +0.05%
Weighted Average Number of Shares Outstanding, Diluted 12,544,777 -0.42%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $9,351,000 -83%
Research and Development Expense $61,198,000 -29%
General and Administrative Expense $23,056,000 +30%
Costs and Expenses $89,786,000 -24%
Operating Income (Loss) $80,435,000 -26%
Nonoperating Income (Expense) $7,016,000 -58%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $73,419,000 -55%
Income Tax Expense (Benefit) $106,000 -165%
Earnings Per Share, Basic -6 +19%
Earnings Per Share, Diluted -6 +19%
Cash and Cash Equivalents, at Carrying Value $40,276,000 -57%
Accounts Receivable, after Allowance for Credit Loss, Current $545,000 -95%
Assets, Current $60,091,000 -55%
Property, Plant and Equipment, Net $98,000 -99%
Operating Lease, Right-of-Use Asset $588,000 -88%
Assets $61,256,000 -58%
Accounts Payable, Current $3,670,000 -67%
Liabilities, Current $16,637,000 -44%
Operating Lease, Liability, Noncurrent $284,000 -92%
Other Liabilities, Noncurrent $9,688,000 +65%
Liabilities $27,176,000 -34%
Accumulated Other Comprehensive Income (Loss), Net of Tax $6,441,000 +13%
Retained Earnings (Accumulated Deficit) $428,191,000 -21%
Stockholders' Equity Attributable to Parent $34,080,000 -67%
Liabilities and Equity $61,256,000 -58%
Other Noncash Income (Expense) $37,000
Share-based Payment Arrangement, Noncash Expense $353,000 -42%
Increase (Decrease) in Accounts Receivable $231,000 -98%
Net Cash Provided by (Used in) Operating Activities $52,000
Net Cash Provided by (Used in) Investing Activities $20,000 +83%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $40,480,000 -56%
Operating Lease, Liability $600,000 -88%
Payments to Acquire Property, Plant, and Equipment $20,000 -83%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $72,352,000 -52%
Property, Plant and Equipment, Gross $1,746,000 -90%
Operating Lease, Liability, Current $312,000 -80%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 +24%
Preferred Stock, Shares Authorized 10,000,000 0%
Additional Paid in Capital $468,711,000 +0.41%
Depreciation, Depletion and Amortization $389,000 -39%
Share-based Payment Arrangement, Expense $1,910,000 +33%
Preferred Stock, Par or Stated Value Per Share 0 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY